Advanced Oncotherapy (AVO)

1.70p
   
  • Change Today:
    -0.100p
  • 52 Week High: 2.65p
  • 52 Week Low: 0.68p
  • Currency: UK Pounds
  • Shares Issued: 359.41m
  • Volume: 297,282
  • Market Cap: £6.11m

Largest Deals (365 days)

Show trades greater than:
Traded Action Notifier PriceAmountValue
25-Apr-13 Buy Michael J Sinclair 1.66p 8,250,000 £136,537.51
24-Apr-13 Buy Michael J Sinclair 1.59p 8,075,000 £128,392.51
24-Apr-13 Buy Michael J Sinclair 1.42p 1,410,000 £20,036.10
25-Apr-13 Buy Timothy Lebus 1.56p 750,000 £11,700.00
25-Apr-13 Buy Timothy Lebus 1.55p 213,000 £3,290.85
26-Apr-13 Placing Michael Bradfield 0.000p 100,000,000 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AVO Market Data

Currency UK Pounds
Share Price 1.70p
Change Today -0.100p
% Change -5.56 %
52 Week High 2.65p
52 Week Low 0.68p
Volume 297,282
Shares Issued 359.41m
Market Cap £6.11m

AVO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
37.45% above the market average37.45% above the market average37.45% above the market average37.45% above the market average37.45% above the market average
32.58% above the sector average32.58% above the sector average32.58% above the sector average32.58% above the sector average32.58% above the sector average
Income Not Available
Growth
67.65% above the market average67.65% above the market average67.65% above the market average67.65% above the market average67.65% above the market average
78.05% above the sector average78.05% above the sector average78.05% above the sector average78.05% above the sector average78.05% above the sector average

AVO Dividends

No dividends found

Trades for 23-May-2013

Time Volume / Share Price
13:10 91,350 @ 1.65p
08:47 62,932 @ 1.67p
08:35 25,000 @ 1.75p
08:33 13,000 @ 1.67p
08:10 25,000 @ 1.75p

AVO Key Personnel

Chair Michael J Sinclair
CEO Paul Stacey
Finance Director Steve Wilden
Finance Director Don Baladasan
COO Sneh Khemka

Top of Page